Prospective randomized comparisons of ranitidine bismuth citrate (RBC) versus colloidal bismuth subcitrate (Denol)-based triple therapy for the treatment of H-pylori infection.

被引：0
|
作者：
Kung, NNS
Sung, JY
Yuen, WF
Li, TH
Ng, PW
Lai, WM
Leung, MF
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Hong Kong
[2] United Christian Hosp, Dept Med, Hong Kong, Hong Kong
[3] United Christian Hosp, Dept Pathol, Hong Kong, Hong Kong
[4] United Christian Hosp, Dept Microbiol, Hong Kong, Hong Kong
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)80774-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G0780
引用
收藏
页码：A190 / A190
页数：1
相关论文
共 50 条
  • [41] Treatment of patients with duodenal ulcer positive for Helicobacter pylori infection: Ranitidine or omeprazole associated with colloidal bismuth subcitrate plus amoxicillin
    Cataldo, MG
    Brancato, D
    Donatelli, M
    Morici, ML
    Aspetti, S
    Spina, P
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (03): : 168 - 174
  • [42] Levofloxacin- vs. ranitidine bismuth citrate-based second-line therapy after H-pylori treatment failure
    Gisbert, Javier P.
    Gisbert, Jose-luis
    Marcos, Santiago
    Pousa, Ines D.
    Velasco, Marta
    Luna, Marta
    Moreno-otero, Ricardo
    Pajares, Jose-maria
    GASTROENTEROLOGY, 2007, 132 (04) : A615 - A615
  • [43] Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection:: a randomized, controlled trial in Vietnamese patients with duodenal ulcer
    Mao, HV
    Lak, BV
    Long, T
    Chung, NQ
    Thang, DM
    Hop, TV
    Chien, NN
    Hoan, PQ
    Henley, KS
    Perez-Perez, GI
    Connor, BA
    Stone, CD
    Chey, WD
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (01) : 97 - 101
  • [44] Efficacy of colloidal bismuth subcitrate, metronidazole, and tetracycline HCl in eradication of H-pylori:: A randomized, placebo-controlled study.
    VanZanten, SV
    Farley, A
    Marcon, N
    Lahaie, R
    Archambault, A
    Hunt, R
    Bailey, R
    Owen, D
    Spénard, J
    Colin, P
    GASTROENTEROLOGY, 1998, 114 (04) : A322 - A322
  • [45] Lansoprazole or ranitidine bismuth citrate based triple therapies for Helicobacter pylori eradication: Results of an open randomized study
    Spadaccini, A
    DeFanis, C
    Sciampa, G
    Pantaleone, U
    DiVirgilio, M
    Pizzicannella, G
    GUT, 1997, 41 : A212 - A212
  • [46] Lansoprazole or ranitidine bismuth citrate based triple therapies for Helicobacter pylori eradication: Results of an open randomized study
    Spadaccini, A
    DeFanis, C
    Sciampa, G
    Pantaleone, U
    DiVirgilio, M
    Pizzicannella, G
    GUT, 1997, 41 : A105 - A105
  • [47] Ranitidine bismuth citrate plus levofloxacin and tinidazole a new alternative therapy in Helicobacter pylori infection.: A preliminary report.
    Magnano, A
    Pallio, S
    Tortora, A
    Melita, G
    Favara, C
    Calzona, A
    Lauria, S
    Greco, S
    GUT, 2000, 47 : A125 - A125
  • [48] Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC):: A randomized comparison between two 7-day triple therapies and a 14-day dual therapy
    de Boer, WA
    Haeck, PWE
    Otten, MH
    Mulder, CJJ
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (07) : 1101 - 1107
  • [49] Triple therapy with low versus high dose azithromycin to treat H-pylori infection.
    Chey, WD
    Fisher, L
    Barnett, J
    Delvalle, J
    Elta, GH
    Nostrant, T
    Palaniappan, J
    Scheiman, J
    GASTROENTEROLOGY, 1998, 114 (04) : A91 - A91
  • [50] Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection
    Graham, DY
    Hoffman, J
    Anderson, SY
    Qureshi, W
    Osato, MS
    El-Zimaity, HMT
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (02) : 169 - 172
12345